AI 90天预测
买入
7天
30天
90天
AI置信度: 4% 斯皮尔曼相关性
三月 31, 2026
价格图表
正在加载图表...
关键统计数据
市值
$738M
市盈率
-0.6x
市净率
11.17x
每股收益
$-13.68
股本回报率
-33.8%
流动比率
10.49x
资产负债率
0.11x
关于 Vor Biopharma Inc.
Vor Biopharma Inc. (VOR) 在Life Sciences行业运营，具体属于Biological Products, (No Diagnostic Substances)业务. 该公司雇佣约159名员工.
We do not have any company description for Vor Biopharma Inc. at the moment.
Biological Products, (No Diagnostic Substances) 同行公司
| 公司 | 股票代码 | AI信号 | 市值 | 市盈率 |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | ██% | $170M | -1.9x |
| Abpro Holdings, Inc. | ABP | ██% | $310K | -x |
| Arcellx, Inc. | ACLX | ██% | $6.65B | -74.1x |
| Alpha Cognition Inc. | ACOG | ██% | $116M | -x |
| Adaptimmune Therapeutics Plc | ADAP | ██% | $77M | -13.2x |
| Adma Biologics, Inc. | ADMA | ██% | $2.18B | 14.8x |
| Adaptive Biotechnologies Corp | ADPT | ██% | $1.98B | -4.6x |
| Adverum Biotechnologies, Inc. | ADVM | ██% | $95M | -1.8x |
| Agenus Inc | AGEN | ██% | $114M | 995.1x |
| Agentix Corp. | AGTX | ██% | $2M | -x |
| Aim Immunotech Inc. | AIM | ██% | $2M | -0.5x |
| Aim Immunotech Inc. | AIMI | ██% | $1M | -x |
| Alector, Inc. | ALEC | ██% | $223M | -1.2x |
| Aligos Therapeutics, Inc. | ALGS | ██% | $41M | -19.2x |
| Allogene Therapeutics, Inc. | ALLO | ██% | $509M | -1.4x |
| Alvotech | ALVO | ██% | $1.07B | -x |
| Amgen Inc | AMGN | ██% | $189.58B | 24.6x |
| Apogee Therapeutics, Inc. | APGE | ██% | $5.38B | -20.5x |
| Aptose Biosciences Inc. | APTOF | ██% | $4M | -x |
| Argenx Se | ARGX | ██% | $41.93B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | ██% | $315M | -1.0x |
| Artiva Biotherapeutics, Inc. | ARTV | ██% | $133M | -x |
| Leonabio, Inc. | ATHA | ██% | $23M | -0.2x |
| Atara Biotherapeutics, Inc. | ATRA | ██% | $35M | 1.1x |
| Atyr Pharma Inc | ATYR | ██% | $76M | -3.6x |
| Aura Biosciences, Inc. | AURA | ██% | $425M | -4.9x |
| Autolus Therapeutics Plc | AUTL | ██% | $386M | -x |
| Anavex Life Sciences … | AVXL | ██% | $261M | -17.3x |
| Bioatla, Inc. | BCAB | ██% | $13M | -1.1x |
| Biocardia, Inc. | BCDA | ██% | $12M | -0.6x |
| Brainstorm Cell Therapeutics … | BCLI | ██% | $8M | -4.9x |
| Biocryst Pharmaceuticals Inc | BCRX | ██% | $2.37B | 9.0x |
| Black Diamond Therapeutics, … | BDTX | ██% | $116M | 5.2x |
| Beam Therapeutics Inc. | BEAM | ██% | $2.23B | -12.6x |
| Biogen Inc. | BIIB | ██% | $27.54B | 21.3x |
| Biontech Se | BNTX | ██% | $21.43B | -x |
| Cabaletta Bio, Inc. | CABA | ██% | $286M | -1.6x |
| Candel Therapeutics, Inc. | CADL | ██% | $328M | -4.6x |
| C4 Therapeutics, Inc. | CCCC | ██% | $228M | -2.6x |
| Cidara Therapeutics, Inc. | CDTX | ██% | $6.49B | -1.0x |
| Creative Medical Technology … | CELZ | ██% | $7M | -3.4x |
| Cero Therapeutics Holdings, … | CERO | ██% | $720K | -x |
| Cullinan Therapeutics, Inc. | CGEM | ██% | $847M | -4.1x |
| Compugen Ltd | CGEN | ██% | $188M | -x |
| Cg Oncology, Inc. | CGON | ██% | $5.16B | -x |
| Cognition Therapeutics Inc | CGTX | ██% | $68M | -0.5x |
| Coherus Oncology, Inc. | CHRS | ██% | $265M | 1.6x |
| Calidi Biotherapeutics, Inc. | CLDI | ██% | $2M | -0.9x |
| Cellectis S.A. | CLLS | ██% | $319M | -x |
| Compass Therapeutics, Inc. | CMPX | ██% | $909M | -4.8x |
| Mosaic Immunoengineering Inc. | CPMV | ██% | $5M | -x |
| Caribou Biosciences, Inc. | CRBU | ██% | $142M | -1.5x |
| Cardiff Oncology, Inc. | CRDF | ██% | $106M | -4.0x |
| Cardiol Therapeutics Inc. | CRDL | ██% | $136M | -x |
| Curis Inc | CRIS | ██% | $20M | -0.3x |
| Crispr Therapeutics Ag | CRSP | ██% | $4.25B | -12.1x |
| Champions Oncology, Inc. | CSBR | ██% | $80M | 32.9x |
| Cel Sci Corp | CVM | ██% | $26M | -0.9x |
| Dbv Technologies S.A. | DBVT | ██% | $1.13B | -3.3x |
| Dbv Technologies S.A. | DBVTF | ██% | $10K | -x |
| Ginkgo Bioworks Holdings, … | DNA | ██% | $319M | -13.9x |
| Denali Therapeutics Inc. | DNLI | ██% | $2.82B | -8.7x |
| Precision Biosciences Inc | DTIL | ██% | $131M | -2.2x |
| Dyadic International Inc | DYAI | ██% | $31M | -7.3x |
| Editas Medicine, Inc. | EDIT | ██% | $218M | -0.8x |
| Elutia Inc. | ELUT | ██% | $44M | 0.8x |
| Engene Holdings Inc. | ENGN | ██% | $414M | 3.7x |
| Entera Bio Ltd. | ENTX | ██% | $51M | 8.5x |
| Viskase Holdings, Inc. | ENZN | ██% | $4M | -x |
| Estrella Immunopharma, Inc. | ESLA | ██% | $42M | -3.1x |
| Evaxion A/S | EVAX | ██% | $31M | -x |
| Exelixis, Inc. | EXEL | ██% | $11.01B | 14.1x |
| Exozymes Inc. | EXOZ | ██% | $61M | -x |
| Fate Therapeutics Inc | FATE | ██% | $122M | -1.3x |
| 4d Molecular Therapeutics, … | FDMT | ██% | $438M | -3.0x |
| Fennec Pharmaceuticals Inc. | FENC | ██% | $210M | 1758.3x |
| Finch Therapeutics Group, … | FNCH | ██% | $15M | -0.1x |
| Futuretech Ii Acquisition … | FTII | ██% | $52M | -x |
| Futuretech Ii Acquisition … | FTIIU | ██% | $14M | -x |
| Gilead Sciences, Inc. | GILD | ██% | $169.20B | 19.9x |
| Monte Rosa Therapeutics, … | GLUE | ██% | $1.32B | 59.5x |
| Genenta Science S.P.A. | GNTA | ██% | $16M | -x |
| Green Planet Bio … | GPLB | ██% | $340K | -x |
| Halozyme Therapeutics, Inc. | HALO | ██% | $7.32B | 23.1x |
| Humacyte, Inc. | HUMA | ██% | $128M | -3.3x |
| Immunitybio, Inc. | IBRX | ██% | $6.74B | -3.6x |
| Inhibikase Therapeutics, Inc. | IKT | ██% | $194M | -1.0x |
| Immunocore Holdings Plc | IMCR | ██% | $1.48B | -x |
| Immatics N.V. | IMTX | ██% | $1.25B | -x |
| Immunovant, Inc. | IMVT | ██% | $4.85B | -14.5x |
| In8bio, Inc. | INAB | ██% | $13M | -x |
| Inhibrx Biosciences, Inc. | INBX | ██% | $873M | -6.8x |
| Mink Therapeutics, Inc. | INKT | ██% | $45M | -1.5x |
| Inmune Bio, Inc. | INMB | ██% | $30M | -2.5x |
| Intensity Therapeutics, Inc. | INTS | ██% | $14M | -2.2x |
| Iovance Biotherapeutics, Inc. | IOVA | ██% | $1.45B | -4.5x |
| Century Therapeutics, Inc. | IPSC | ██% | $365M | -0.7x |
| Invivyd, Inc. | IVVD | ██% | $367M | -0.4x |
| Jasper Therapeutics, Inc. | JSPR | ██% | $25M | -3.2x |
| Kalaris Therapeutics, Inc. | KLRS | ██% | $121M | -x |
| Klotho Neurosciences, Inc. | KLTO | ██% | $56M | -x |
| Kodiak Sciences Inc. | KOD | ██% | $2.35B | -2.5x |
| Krystal Biotech, Inc. | KRYS | ██% | $7.21B | 35.2x |
| Kymera Therapeutics, Inc. | KYMR | ██% | $6.46B | -17.8x |
| Kyverna Therapeutics, Inc. | KYTX | ██% | $458M | -x |
| Ladrx Corp | LADX | ██% | $20K | -x |
| Lineage Cell Therapeutics, … | LCTX | ██% | $360M | -4.7x |
| Lenz Therapeutics, Inc. | LENZ | ██% | $357M | -6.7x |
| Liminatus Pharma, Inc. | LIMN | ██% | $10M | -x |
| Lexeo Therapeutics, Inc. | LXEO | ██% | $385M | -0.4x |
| Maze Therapeutics, Inc. | MAZE | ██% | $1.43B | -x |
| Mesoblast Ltd | MESO | ██% | $1.90B | -x |
| Meiragtx Holdings Plc | MGTX | ██% | $596M | -3.4x |
| Metagenomi Therapeutics, Inc. | MGX | ██% | $50M | -x |
| Molecular Partners Ag | MOLN | ██% | $160M | -x |
| Moderna, Inc. | MRNA | ██% | $20.02B | -3.2x |
| Neurocrine Biosciences Inc | NBIX | ██% | $12.80B | 26.7x |
| Nkgen Biotech, Inc. | NKGN | ██% | $2M | -0.1x |
| Neumora Therapeutics, Inc. | NMRA | ██% | $399M | -3.9x |
| Novavax Inc | NVAX | ██% | $1.51B | 3.4x |
| Ocugen, Inc. | OCGN | ██% | $547M | -4.3x |
| Outlook Therapeutics, Inc. | OTLK | ██% | $22M | -0.2x |
| Palisade Bio, Inc. | PALI | ██% | $291M | -0.2x |
| Passage Bio, Inc. | PASG | ██% | $22M | -0.6x |
| Vaxcyte, Inc. | PCVX | ██% | $7.62B | -20.4x |
| Biomx Inc. | PHGE | ██% | $8M | 1.5x |
| Pluri Inc. | PLUR | ██% | $34M | -1.4x |
| Protalix Biotherapeutics, Inc. | PLX | ██% | $173M | 41.2x |
| Pharmacyte Biotech, Inc. | PMCB | ██% | $8M | 0.3x |
| Prime Medicine, Inc. | PRME | ██% | $617M | -1.5x |
| Prokidney Corp. | PROK | ██% | $526M | -x |
| Qiagen N.V. | QGEN | ██% | $9.11B | -x |
| Quince Therapeutics, Inc. | QNCX | ██% | $5M | -1.7x |
| Qrons Inc. | QRON | ██% | $150K | -x |
| Replimune Group, Inc. | REPL | ██% | $602M | -3.8x |
| Repligen Corp | RGEN | ██% | $6.61B | 135.2x |
| Regenxbio Inc. | RGNX | ██% | $418M | -1.8x |
| Relay Therapeutics, Inc. | RLAY | ██% | $1.84B | -2.0x |
| Revolution Medicines, Inc. | RVMD | ██% | $19.08B | -11.1x |
| Recursion Pharmaceuticals, Inc. | RXRX | ██% | $1.58B | -4.7x |
| Sab Biotherapeutics, Inc. | SABS | ██% | $273M | 20.6x |
| Sana Biotechnology, Inc. | SANA | ██% | $740M | -2.1x |
| Scilex Holding Co | SCLX | ██% | $47M | -0.4x |
| Scinai Immunotherapeutics Ltd. | SCNI | ██% | $2M | -287.8x |
| Sangamo Therapeutics, Inc | SGMO | ██% | $82M | -1.6x |
| Solid Biosciences Inc. | SLDB | ██% | $715M | -0.9x |
| Silexion Therapeutics Corp | SLXN | ██% | $4M | -x |
| Senti Biosciences, Inc. | SNTI | ██% | $24M | -1.1x |
| Scholar Rock Holding … | SRRK | ██% | $5.22B | -18.5x |
| Surrozen, Inc./De | SRZN | ██% | $343M | -0.5x |
| Sutro Biopharma, Inc. | STRO | ██% | $356M | -1.0x |
| Protara Therapeutics, Inc. | TARA | ██% | $278M | -2.1x |
| Tarsus Pharmaceuticals, Inc. | TARS | ██% | $2.87B | -12.4x |
| Tc Biopharm (Holdings) … | TCBPY | ██% | $10K | -x |
| Tscan Therapeutics, Inc. | TCRX | ██% | $57M | -4.6x |
| Bio-Techne Corp | TECH | ██% | $8.20B | 101.1x |
| Tectonic Therapeutic, Inc. | TECX | ██% | $587M | -8.9x |
| Instil Bio, Inc. | TIL | ██% | $56M | -1.1x |
| Tenaya Therapeutics, Inc. | TNYA | ██% | $159M | -2.5x |
| Tourmaline Bio, Inc. | TRML | ██% | $1.23B | -3.5x |
| Taysha Gene Therapies, … | TSHA | ██% | $1.26B | -3.0x |
| Titan Pharmaceuticals Inc | TTNP | ██% | $6M | -0.5x |
| Tevogen Bio Holdings … | TVGN | ██% | $17M | -x |
| Twist Bioscience Corp | TWST | ██% | $2.85B | -12.6x |
| Voyager Acquisition Corp./Cayman … | VACH | ██% | $372M | 41.3x |
| Voyager Acquisition Corp./Cayman … | VACHU | ██% | $68M | 6.7x |
| Valneva Se | VALN | ██% | $548M | -x |
| Vericel Corp | VCEL | ██% | $1.61B | 97.7x |
| Vir Biotechnology, Inc. | VIR | ██% | $1.47B | -2.0x |
| Vivosim Labs, Inc. | VIVS | ██% | $4M | -x |
| Vor Biopharma Inc. | VOR | ██% | $738M | -0.6x |
| Vaxart, Inc. | VXRT | ██% | $146M | 8.9x |
| Voyager Therapeutics, Inc. | VYGR | ██% | $238M | 570.6x |
| Windtree Therapeutics Inc … | WINT | ██% | $320K | -0.4x |
| X4 Pharmaceuticals, Inc | XFOR | ██% | $375M | 6.4x |
| Zeo Scientifix, Inc. | ZEOX | ██% | $17M | -x |
| Zivo Bioscience, Inc. | ZIVO | ██% | $26M | -31.3x |
| Zura Bio Ltd | ZURA | ██% | $565M | -x |
常见问题
-
Vor Biopharma Inc.是值得买入的好股票吗？
我们的AI每天分析Vor Biopharma Inc.。查看上方信号获取最新建议。投资前请务必自行研究。
-
Vor Biopharma Inc.的预测有多准确？
我们的AI在该股票的斯皮尔曼相关性达到4%，每天分析的4,000+只股票中平均准确率超过67%。
-
预测多久更新一次？
Vor Biopharma Inc.的预测使用最新市场数据和AI模型每天更新。
想要Vor Biopharma Inc.的更深入分析吗？
在Intratio上查看完整的机构级分析 →AI预测基于历史模式，不应作为投资决策的唯一依据。过往表现不保证未来结果。请务必自行研究。